{
  "nctId": "NCT05989087",
  "briefTitle": "The Resting-state EEG Gamma Oscillations in Alzheimer's Disease",
  "officialTitle": "The Underestimated Utility of Resting-state Gamma Oscillations: Both Increase and Decrease of Gamma Discriminates Early-onset Alzheimer's Disease Patients From Healthy Individuals",
  "protocolDocument": {
    "nctId": "NCT05989087",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2023-07-25",
    "uploadDate": "2023-07-25T09:31",
    "size": 421800,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05989087/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 51,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2012-11-07",
    "completionDate": "2019-04-05",
    "primaryCompletionDate": "2016-01-02",
    "firstSubmitDate": "2023-07-25",
    "firstPostDate": "2023-08-14"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* For all participants: Age \\< 65\n* For EOAD patients: Meeting National Institute on Aging-Alzheimer's Association diagnostic criteria.\n* For healthy controls: Mini-Mental State Examination (MMSE) \\>25 Instrumental Activities of Daily Living Scale (IADL) = 8\n\nExclusion Criteria:\n\n* For EOAD patients: MMSE \\> 24 Geriatric depression scale (GDS) \\> 14 Having treatment with antipsychotics and comorbidities that may affect cognitive abilities.\n* For healthy controls: Having neurological and/or cognitive abnormalities Having a history of neurological, psychiatric, or systemic disorders, and alcohol/drug abuse. GDS \\> 14\n* For all participants: Having neurological (other than AD) or any other serious disease (cancer, systemic disease)",
    "healthyVolunteers": true,
    "sex": "ALL",
    "maximumAge": "65 Years",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "EEG",
        "description": "The resting state EEG recordings were acquired using Easy-Cap comprising 30 Ag/AgCl electrodes placed according to the international 10-20 system. Coherence and maximum peak power of the total gamma (30-48 Hz) and sub-gamma bands \\[gamma-1 (30-35 Hz), gamma-2 (35-40 Hz), and gamma-3 (40-48 Hz)\\] were measured for each participant.",
        "timeFrame": "Day 2"
      }
    ],
    "secondary": [
      {
        "measure": "Correlation Analysis",
        "description": "Correlations between CSF, neuropsychological tests (NPT), EEG, and MRI measures were investigated.",
        "timeFrame": "3 months"
      },
      {
        "measure": "Discriminant Analysis",
        "description": "The discriminative power of gamma measures (power and coherence) was investigated with discriminant analysis (DA).",
        "timeFrame": "3 months"
      },
      {
        "measure": "MRI",
        "description": "Participants underwent structural magnetic resonance imaging on a Philips Achieva 1.5 Tesla scanner. The gray matter volumes were obtained from the 3D-T1 weighted Turbo field echo (TFE) sequence (TR: 9ms, Time to Echo (TE): 4ms, Field-of-view (FOV): 240mm, matrix: 256, slice thickness: 1mm, numbers of signal averages (NSA): 1). The images were segmented into gray matter, white matter, and CSF with the default parameters of the CAT12 segmentation function. Only the gray matter calculations were compared between groups.",
        "timeFrame": "Day 1"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 3,
      "otherCount": 0,
      "totalCount": 4
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 44,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:34:00.783Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}